reports
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provi...
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update –Update on FDA Inspection of Buena Facility–Assessing New Growth Opportunities in Injectables–Conference Call to Be Held on August 16, 2021 at 8:30 am Eastern Standard Time –Dial in: (877) 407-0792 US Toll Free Number (201) 689-8263 International Number Confirmation Number: 13721972 BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a busi...
Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financi...
Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021 BUENA, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference call at 8:30AM ET on Monday, August 16th, 2021 to discuss the second quarter ended June 30, 2021 financial results and business update. Conference Call InformationDate: Monday, August 16, 2021Time: 8:30 a.m. Eastern TimeDial-in numbers: Toll Free: 877-407-0792 International: 201-6...
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders Scheduled to Reconvene on July 21, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 30, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today that its Annual Meeting of Stockholders, scheduled for June 18, 2021 and adjourned to June 30, 2021, was convened and adjourned without any business being conducted due to the fact that there were not sufficient votes to approve all of the proposals presented at t...
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders Scheduled to Reconvene on June 30, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 18, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today that its Annual Meeting of Stockholders, scheduled for June 18, 2021, was convened and adjourned without any business being conducted due to the fact that there were not sufficient votes to approve all of the proposals presented at the Annual Meeting. The Company ...
Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provid...
Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update –Continued Remediation Progress Being Made–Reiterating Prior Guidance of Informing FDA on Inspection Readiness During 3Q2021–Conference Call to Be Held on May 25, 2021 at 4:30 pm Eastern Standard Time –Dial in: (800) 708-4540 US Toll Free Number (847) 619-6397 US Number Confirmation Number: 50161966 BUENA, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the first quarter of 2021 and pr...
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financia...
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020 BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference call at 8:30AM ET on Tuesday, May 25th, 2021 to discuss the first quarter ended March 31, 2021 financial results and business update. Conference Call InformationDate: Tuesday, May 25, 2021Time: 8:30 a.m. Eastern TimeDial-in numbers: Toll Free: (866) 393-8366 International: 409-350-3154...
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Bu...
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update – Significantly strengthened balance sheet and cash position – Continued FDA Warning Letter remediation efforts – Anticipate informing FDA on inspection readiness during 3Q2021 – Conference Call to be held on May 4, 2021 at 4:30 pm Eastern Standard Time – Dial in: (800) 708-4540 US Toll Free Number (847) 619-6397 US Number Confirmation Number: 50161966 BUENA, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its fi...
Teligent Announces Hiring of Chief Financial Officer
Teligent Announces Hiring of Chief Financial Officer BUENA, N.J., April 15, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced the hiring and appointment of Ernest R. De Paolantonio as Chief Financial Officer of the Company, effective April 15, 2021. Timothy B. Sawyer, President and CEO of the Company, commented, “We are very pleased that Ernie has agreed to join our Teligent team. Over the last several months, we have made key additions to our leadership team, and the appointm...
Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq...
Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received notice from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company not having timely filed its Quarterly Report on Form 10-Q for the three months ended September 30, 2020 (the “Form 10-Q”) with the Securities and Exchan...
Teligent, Inc. Announces Third Quarter 2020 Results
Teligent, Inc. Announces Third Quarter 2020 Results BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2020. Financial Highlights Third Quarter 2020 vs. Second Quarter 2020 Revenues of $14.3 million, an increase of $0.8 million or 6%, on stronger demand for US topical productsGross profit of $0.1 million, a decrease of $2.4 million driven by additional inventory reserves an...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholder...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders Scheduled to Reconvene on December 16, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today that its Special Meeting of Stockholders, scheduled for October 22, 2020, adjourned to November 11, 2020 and then to November 25, 2020, was convened and adjourned without any business being conducted due to the fact that a quorum was not achieved on the propo...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholder...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders Scheduled to Reconvene on November 25, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today that its Special Meeting of Stockholders, scheduled for October 22, 2020 and adjourned to November 11, 2020, was convened and adjourned without any business being conducted due to the fact that a quorum was not achieved on the proposals to be approved. Stockh...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholder...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders Scheduled to Reconvene on November 11, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today that its Special Meeting of Stockholders, scheduled for October 22, 2020, was convened and adjourned without any business being conducted due to the fact that a quorum was not achieved on the proposals to be approved. Stockholders have thus far strongly suppo...
- Jonathan Moreland
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
TLGT TELIGENT INC.
SCM STELLUS CAPITAL INVESTMENT CORP
QTNT QUOTIENT LTD
PRGS PROGRESS SOFTWARE CORPORATION
OFC CORPORATE OFFICE PROPERTIES TRUST
MRLN MARLIN BUSINESS SERVICES CORP.
IMMU IMMUNOMEDICS INC.
HIW HIGHWOODS PROPERTIES INC.
HIG HARTFORD FINANCIAL SERVICES GROUP INC.
FSP FRANKLIN STREET PROPERTIES CORP.
CRY CRYOLIFE INC.
CPRX CATALYST PHARMACEUTICALS
CLRO CLEARONE
CLR CONTINENTAL RESOURCES INC.
CIO CITY OFFICE REIT INC.
CBLAQ CBL & ASSOCIATES PROPERTIES INC.
AAIC ARLINGTON ASSET INVESTMENT CORP. CLASS A
AEL AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
PCYO PURE CYCLE CORP.
SAFT SAFETY INSURANCE GROUP INC.
OASPQ OASIS PETROLEUM INC.
GOVX GEOVAX LABS INC
DRQ DRIL-QUIP INC.
SCS STEELCASE INC. CLASS A
TRC TEJON RANCH CO.
ACNB ACNB CORP.
GCBC GREENE COUNTY BANCORP INC.
EDF STONE HARBOR EMERGING MARKETS INCOME FUND
CTHR CHARLES & COLVARD LTD.
SOR SOURCE CAPITAL INC.
HOME AT HOME GROUP INC.
MRUS MERUS B V
EQBK EQUITY BANCSHARES
TLRS TIMBERLINE RESOURCES CORP.
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
GECC GREAT ELM CAPITAL CORP
VICI VICI PROPERTIES INC
OFG ORIENTAL FINANCIAL GROUP
NWGI INC.
ALRT NEWGIOCO GROUP
KOD INC.
NEON ALR TECHNOLOGIES
CI KODIAK SCIENCES
SAVA NEONODE INC.
APRN CIGNA CORPORATION
STND CASSAVA SCIENCES
TA BLUE APRON HOLDINGS
HBT STANDARD AVB FINANCIAL CORP
NKLA TRAVELCENTERS OF AMERICA INC
FUBO HBT FINANCIAL
RYES NIKOLA CORPORATION
TARA FUBOTV INC.
PATRIOT MINEFINDERS INC.
PROTEON THERAPEUTICS INC
Teligent, Inc. Announces Second Quarter 2020 Results
Teligent, Inc. Announces Second Quarter 2020 Results BUENA, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2020. Financial Highlights Second Quarter 2020 vs. First Quarter 2020 Revenues of $13.6 million, an increase of $6.1 million or 82%, stronger demand for both US topical products and injectable products sold in Canada Gross profit of $2.5 million, an increase of $3.7 million or 315% driven by the increase in revenues Produ...
Teligent, Inc. to Hold Conference Call for Second Quarter 2020 Financi...
Teligent, Inc. to Hold Conference Call for Second Quarter 2020 Financial Results and Business Update on Wednesday August 19th, 2020 BUENA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on Wednesday August 19th, 2020 to discuss the 2nd quarter 2020 financial results and business update. The Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the...
Teligent Announces Completion of Series C Convertible Note Financing a...
Teligent Announces Completion of Series C Convertible Note Financing and Exchange BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the issuance of $13.8 million aggregate principal amount of 9.5% Series C Senior Convertible Notes due 2023 (the “New 2023 Notes”). After taking into account an original issue discount and other transaction fees (including fees payable to the purchasers in the form of additional New 2023 Notes), the Company received a...
Teligent, Inc. Announces the Appointment of John Celentano as Chairman...
Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, is pleased to announce that John Celentano, a current independent director of Teligent, has been appointed Chairman of Teligent's Board of Directors, replacing James C. Gale who opted to not stand for reelection to Teligent’s board of directors in order to devote more time to other business interests. Mr. Celentano joined Teligent as a dir...
Teligent, Inc. Announces Hiring of Chief Legal Officer and Corporate S...
Teligent, Inc. Announces Hiring of Chief Legal Officer and Corporate Secretary BUENA, N.J., July 17, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced the hiring of Philip Yachmetz as Chief Legal Officer and Corporate Secretary of the Company, effective July 16, 2020. Timothy B. Sawyer, President and CEO of the Company, commented, “We are pleased that Phil has agreed to join our Teligent team. Phil’s extensive experience as a general counsel/chief legal and compliance officer...
Teligent Regains Compliance with NASDAQ Listing Requirements
Teligent Regains Compliance with NASDAQ Listing Requirements BUENA, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that it received notice from The NASDAQ Stock Market LLC (“NASDAQ”) on June 18, 2020 indicating that the Company has regained compliance with NASDAQ Listing Rule 5450(a)(1), which requires the Company’s common stock to maintain a minimum bid price of $1.00 per share. The NASDAQ staff made this determination of compliance after the closing bid pric...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.